Pages that link to "Q40551097"

The following pages link to Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. (Q40551097):

Displaying 41 items.

• Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus (Q21131361) (← links)
• Coronavirus reverse genetic systems: infectious clones and replicons (Q26863163) (← links)
• Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion (Q30276258) (← links)
• Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation. (Q30577917) (← links)
• Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines (Q33294059) (← links)
• High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery (Q33347218) (← links)
• Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage (Q33614408) (← links)
• Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro (Q33788800) (← links)
• Selective replication of coronavirus genomes that express nucleocapsid protein (Q33788868) (← links)
• Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo (Q33834964) (← links)
• The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication (Q34092836) (← links)
• Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination (Q34193444) (← links)
• Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication (Q35785423) (← links)
• Role of interferons in the treatment of severe acute respiratory syndrome (Q35790834) (← links)
• Molecular biology of severe acute respiratory syndrome coronavirus (Q35883052) (← links)
• New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus (Q36058647) (← links)
• Current status of anti-SARS agents (Q36058652) (← links)
• Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicase gene products, and the extreme 3' end of the mouse coronavirus genome (Q36424173) (← links)
• Genome organization and reverse genetic analysis of a type I feline coronavirus (Q36483272) (← links)
• Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1''-phosphatase, a viral function conserved in the alpha-like supergroup (Q36994677) (← links)
• Human coronaviruses 229E and NL63: close yet still so far. (Q37445334) (← links)
• Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle. (Q37481314) (← links)
• Chronic beta-AR activation-induced calpain activation and impaired eNOS-Akt signaling mediates cardiac injury in ovariectomized female rats (Q37486435) (← links)
• Reprint of: Coronavirus reverse genetic systems: infectious clones and replicons. (Q38254831) (← links)
• Identification and characterization of a Golgi retention signal in feline coronavirus accessory protein 7b. (Q38652217) (← links)
• Characterization of White bream virus reveals a novel genetic cluster of nidoviruses (Q39321492) (← links)
• Generation of recombinant coronaviruses using vaccinia virus as the cloning vector and stable cell lines containing coronaviral replicon RNAs (Q39908594) (← links)
• Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway. (Q40095278) (← links)
• Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening (Q40209539) (← links)
• Identification and evaluation of coronavirus replicase inhibitors using a replicon cell line (Q40220718) (← links)
• ADP-ribose-1"-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture (Q40368070) (← links)
• Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus (Q40408546) (← links)
• Homology modeling and virtual screening for antagonists of protease from yellow head virus. (Q42235600) (← links)
• Structural and functional conservation of cis-acting RNA elements in coronavirus 5'-terminal genome regions. (Q47337865) (← links)
• Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus (Q57989514) (← links)
• Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis (Q59355602) (← links)
• S gene and 5a accessory gene are responsible for the attenuation of virulent infectious bronchitis coronavirus (Q84315434) (← links)
• Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis (Q84315550) (← links)
• Viral replicons as valuable tools for drug discovery (Q91767093) (← links)
• Successful establishment of a reverse genetic system for QX-type infectious bronchitis virus and technical improvement of the rescue procedure (Q92728208) (← links)
• Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit (Q107343678) (← links)